Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Q BioMed Inc (QBIO)
OTHER OTC:QBIO
Holding QBIO?
Track your performance easily
QBIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume18.64K
Average Volume (3M)N/A
Market Cap
$145.00
Enterprise Value$4.06M
Total Cash (Recent Filing)$23.17K
Total Debt (Recent Filing)$4.08M
Price to Earnings (P/E)―
Beta-53.77
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding145,094,531
10 Day Avg. Volume3,964
30 Day Avg. VolumeN/A
Standard Deviation51.52
R-Squared0.00673
Alpha5.63
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue19.40
Enterprise Value/Gross Profit-451.74
Enterprise Value/Ebitda-6.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Q BioMed News
PremiumPress Releases
Q BioMed Inc. Provides Update to ShareholdersOwnership Overview
2.47%
Insiders
0.00%
Mutual Funds
<0.01% Other Institutional Investors
97.52% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
QBIO FAQ
What was Q BioMed Inc’s price range in the past 12 months?
Currently, no data Available
What is Q BioMed Inc’s market cap?
Currently, no data Available
When is Q BioMed Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Q BioMed Inc’s earnings last quarter?
Currently, no data Available
Is Q BioMed Inc overvalued?
According to Wall Street analysts Q BioMed Inc’s price is currently Overvalued.
Does Q BioMed Inc pay dividends?
Q BioMed Inc does not currently pay dividends.
What is Q BioMed Inc’s EPS estimate?
Q BioMed Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Q BioMed Inc have?
Q BioMed Inc has 145,094,530 shares outstanding.
What happened to Q BioMed Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Q BioMed Inc?
Currently, no hedge funds are holding shares in QBIO
---
Company Description
Q BioMed Inc
Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring, licensing, and providing resources to life sciences and healthcare companies. Its products include Strontium 89, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.
---
Brainstorm Cell Therapeutics
―
Bioxcel Therapeutics
―
Cyclacel Pharmaceuticals
―
Citius Pharmaceuticals
―
---